Importance The COVID-19 pandemic has been associated with a transient decrease in
bronchiolitis hospitalizations compared with prepandemic patterns, but current effects …

BACKGROUND AND OBJECTIVES There is a paucity of multicenter data on rates of high
flow nasal cannula (HFNC) usage in bronchiolitis in the United States, largely because of …

OBJECTIVES Many interventions in bronchiolitis are low-value or poorly studied. Inpatient
bronchiolitis management is multidisciplinary, with varying degrees of registered nurse (RN) …

BACKGROUND: Heated humidified high-flow nasal cannula (HFNC) is a respiratory support
device historically used in pediatrics for infants with bronchiolitis. No large-scale analysis …

BACKGROUND High-flow nasal cannula oxygen therapy (HFNC) is increasingly used to
treat bronchiolitis. However, HFNC has not reduced time on supplemental oxygen, length of …

METHODS This is a multicenter retrospective study of infants< 12 months of age with
bronchiolitis from 49 children's hospitals from 2010 to 2018. The primary outcomes were …

OBJECTIVES To describe the current state of non-ICU high flow nasal cannula (HFNC)
protocols at children's hospitals and explore associations between HFNC protocol type and …

Importance Admissions to the pediatric intensive care unit (PICU) due to bronchiolitis are
increasing. Whether this increase is associated with changes in noninvasive respiratory …

Background High‐flow nasal cannula (HFNC) therapy is widely used for children with
bronchiolitis, but its optimal role remains uncertain. Our institution created and later revised …

BACKGROUND AND OBJECTIVES High-flow nasal cannula (HFNC) in children
hospitalized with bronchiolitis does not significantly improve clinical outcomes but can …